Viewing Study NCT04877132


Ignite Creation Date: 2025-12-24 @ 9:54 PM
Ignite Modification Date: 2025-12-25 @ 7:33 PM
Study NCT ID: NCT04877132
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2022-09-19
First Post: 2021-05-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Compassionate Use Program for Olipudase Alfa Enzyme Replacement Therapy for Patients With Chronic Acid Sphingomyelinase Deficiency (ASMD)
Sponsor: Sanofi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module